An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma.

Xiong W, Wu X, Starnes S, Johnson SK, Haessler J, Wang S, Chen L, Barlogie B, Shaughnessy JD, Zhan F. An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood. 2008 Nov 15; 112(10):4235-46.

View in: PubMed

subject areas

Aged
Cell Line, Tumor
DNA Damage
Female
Gene Deletion
Gene Expression Regulation, Neoplastic
Genes, Neoplasm
Humans
Male
Middle Aged
Multiple Myeloma
Risk Factors
Tumor Suppressor Protein p53

authors with profiles

Sarah Johnson
Fenghuang Zhan